Overview
Bradley Icard is a Pulmonary Medicine provider in Pinehurst, North Carolina. Dr. Icard is rated as an Experienced provider by MediFind in the treatment of Bronchiectasis. His top areas of expertise are Lung Cancer, Lung Nodules, Squamous Cell Lung Carcinoma, and Large-Cell Lung Carcinoma. Dr. Icard is currently accepting new patients.
His clinical research consists of co-authoring 5 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
205 Page Rd, Pinehurst, NC 28374
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Michael Knowles is a Pulmonary Medicine provider in Chapel Hill, North Carolina. Dr. Knowles is rated as an Elite provider by MediFind in the treatment of Bronchiectasis. His top areas of expertise are Ciliary Dyskinesia-Bronchiectasis, Bronchiectasis, Cystic Fibrosis, Kartagener Syndrome, and Myringotomy.
Peadar Noone is a Pulmonary Medicine provider in Chapel Hill, North Carolina. Dr. Noone is rated as a Distinguished provider by MediFind in the treatment of Bronchiectasis. His top areas of expertise are Bronchiectasis, Kartagener Syndrome, Ciliary Dyskinesia-Bronchiectasis, Cystic Fibrosis, and Lung Transplant. Dr. Noone is currently accepting new patients.
University Of North Carolina At Chapel Hill
Kenneth Olivier is a Pulmonary Medicine provider in Chapel Hill, North Carolina. Dr. Olivier is rated as a Distinguished provider by MediFind in the treatment of Bronchiectasis. His top areas of expertise are Bronchiectasis, Nontuberculous Mycobacterial Lung Disease, Mycobacterium Avium Complex Infections, and Kartagener Syndrome. Dr. Olivier is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerDr. Icard isAdvanced. Learn about Lung Cancer.
- Lung NodulesDr. Icard isAdvanced. Learn about Lung Nodules.
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer
- BronchiectasisDr. Icard isExperienced. Learn about Bronchiectasis.
- Chronic Obstructive Pulmonary Disease (COPD)
- EGFR Positive Lung CancerDr. Icard isExperienced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Icard isExperienced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Icard isExperienced. Learn about Lung Adenocarcinoma.